Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
News

Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr

Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023

  • By IPP Bureau | November 15, 2023

Solara Active Pharma Sciences Limited has reported consolidated financial results for the period ended September 30, 2023.

Solara Active Pharma Sciences has posted net loss of Rs. 17.16 crores for the period ended September 30, 2023 as against net loss of Rs. 19.55 crores for the period ended June 30, 2023.The company has posted net loss of Rs.-.96 crores for the period ended September 30, 2022.

Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023 as compared to Rs. 354.35 crores during the period ended June 30, 2023. The company reported total income of Rs.342.09 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Solara Active Pharma Sciences has reported total income of Rs.780.77 crores as compared to Rs.679.14 crores during the 6 Months period ended September 30, 2022.

The company has posted net loss of Rs. 36.71 crores for the 6 Months period ended September 30, 2023 as against net loss of Rs.26.39 crores for the 6 Months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization